Skip to main content
Premium Trial:

Request an Annual Quote

Decode s Q2 Revenue Climbs 19 Percent, Loss Remains Flat

NEW YORK, Aug. 3 (GenomeWeb News) - Decode Genetics yesterday reported increased revenues and a flat net loss for the second quarter of 2005.


Revenues for the quarter were $11.4 million, up 19 percent over last year's revenues of $9.6 million during the same period.


Research and development costs more than doubled, to $11 million from $5.4 million during the year-ago period. This increase was due to costs of clinical trials, according to the company.


Decode's net loss for the quarter remained flat at $13.3 million, or $.25 per share.


As of June 30, Decode had $185.3 million in cash and short-term investments, including restricted cash.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.